SE7901493L - Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel - Google Patents

Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel

Info

Publication number
SE7901493L
SE7901493L SE7901493A SE7901493A SE7901493L SE 7901493 L SE7901493 L SE 7901493L SE 7901493 A SE7901493 A SE 7901493A SE 7901493 A SE7901493 A SE 7901493A SE 7901493 L SE7901493 L SE 7901493L
Authority
SE
Sweden
Prior art keywords
medicines
preparation
methods
amide derivatives
carbonic acids
Prior art date
Application number
SE7901493A
Other languages
English (en)
Other versions
SE446450B (sv
Inventor
J-F Ancher
T Imbert
B Bucher
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7804921A external-priority patent/FR2417506A1/fr
Priority claimed from FR7902286A external-priority patent/FR2457286A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE7901493L publication Critical patent/SE7901493L/sv
Publication of SE446450B publication Critical patent/SE446450B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7901493A 1978-02-21 1979-02-20 Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning SE446450B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7804921A FR2417506A1 (fr) 1978-02-21 1978-02-21 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme
FR7902286A FR2457286A2 (fr) 1979-01-30 1979-01-30 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
SE7901493L true SE7901493L (sv) 1979-08-22
SE446450B SE446450B (sv) 1986-09-15

Family

ID=26220449

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7901493A SE446450B (sv) 1978-02-21 1979-02-20 Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning

Country Status (13)

Country Link
US (1) US4250178A (sv)
JP (1) JPS54130585A (sv)
AU (1) AU526298B2 (sv)
CA (1) CA1096868A (sv)
CH (1) CH639078A5 (sv)
DE (1) DE2906461A1 (sv)
ES (1) ES477852A1 (sv)
GB (1) GB2014984B (sv)
GR (1) GR66581B (sv)
IT (1) IT1113438B (sv)
LU (1) LU80937A1 (sv)
NL (1) NL7901333A (sv)
SE (1) SE446450B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112617B1 (en) * 1982-11-04 1986-12-30 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
US4743605A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
US5811428A (en) * 1995-12-18 1998-09-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
EP0850228A1 (en) * 1995-09-01 1998-07-01 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
ATE284684T1 (de) * 1997-10-27 2005-01-15 Sumitomo Pharma Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
US7504396B2 (en) * 2003-06-24 2009-03-17 Amgen Inc. Substituted heterocyclic compounds and methods of use
TW200827346A (en) 2006-11-03 2008-07-01 Astrazeneca Ab Chemical compounds
TW200836719A (en) * 2007-02-12 2008-09-16 Astrazeneca Ab Chemical compounds
US7951833B2 (en) * 2008-02-04 2011-05-31 Astrazeneca Ab Crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic acid 471
MX2010011591A (es) * 2008-04-22 2010-11-09 Astrazeneca Ab Pirimidin-5-carboxamidas sustituidas 281.
EP3193609A4 (en) * 2014-09-10 2018-02-28 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789979A (en) * 1954-09-22 1957-04-23 Searle & Co Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof

Also Published As

Publication number Publication date
DE2906461A1 (de) 1979-08-23
GB2014984B (en) 1982-06-09
CA1096868A (en) 1981-03-03
NL7901333A (nl) 1979-08-23
SE446450B (sv) 1986-09-15
AU4439279A (en) 1979-07-19
GR66581B (sv) 1981-03-27
US4250178A (en) 1981-02-10
LU80937A1 (fr) 1979-10-29
IT1113438B (it) 1986-01-20
AU526298B2 (en) 1983-01-06
JPS54130585A (en) 1979-10-09
IT7920206A0 (it) 1979-02-15
CH639078A5 (fr) 1983-10-31
ES477852A1 (es) 1979-08-01
GB2014984A (en) 1979-09-05

Similar Documents

Publication Publication Date Title
SE7805949L (sv) Spiroaminderivat och forfarande for framstellning derav och anvendning derav
SE7901493L (sv) Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
SE7813352L (sv) Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma
SE7705143L (sv) Nya omega-aminokarboxylsyraamider jemte sett for deras framstellning
SE8002293L (sv) Nya antisekretoriska foreningar och deras anvendningsomrade
SE7909916L (sv) Beta,gamma-dihydropolyprenylalkoholer och farmaceutiska kompositioner innehallande desamma
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7908168L (sv) Cysteinderivat
AU588065B2 (en) Substituted diazaoxaspirodecanes, preparation thereof and use thereof as stabilizers for polymers
GB1471847A (en) Dibenzofuran derivatives
ATE4117T1 (de) Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel.
FI872719A0 (fi) Nya tetrahydro-benzotiazoler, deras framstaellning och anvaendning.
SE7901337L (sv) Optiskt aktiv bensamid, sett att framstella denna och farmaceutiska kompositioner innehallande densamma
MX9412A (es) Derivados del acido ciclopropano carboxilico, su procedimiento de preparacion y su aplicacion como pesticidas
SE8405430L (sv) 7-acylindolforeningar, lempade som mellanprodukter vid synteser av 7-acylindolin-2-oner
ATE46687T1 (de) Basisch substituierte phenylacetaldehyde, ihre herstellung und diese enthaltende arzneimittel.
SE8103983L (sv) Heterocykliska foreningar, deras framstellning och farmaceutiska kompositioner innehallande dessa
SE7505272L (sv) Nya, kvevehaltiga, polycykliska foreningar jemte sett for deras framstellning.
SE7700962L (sv) Organiska foreningar, deras framstellning och anvendning
NO904708D0 (no) Fremgangsmaate for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksid-(1r-2r).
SE7902724L (sv) Substituerade n-iminometylpiperidiner
FI911616A (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
NL7513915A (nl) Werkwijze ter bereiding van nieuwe chemische verbindingen.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7901493-2

Effective date: 19870915

Format of ref document f/p: F